Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 4
2005 5
2006 5
2008 2
2009 10
2010 5
2011 2
2012 6
2013 17
2014 9
2015 5
2016 9
2017 10
2018 3
2019 3
2020 3
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 18098192

94 results

Results by year

Filters applied: . Clear all
Page 1
Approaches for prevention of restenosis.
Kraitzer A, Kloog Y, Zilberman M. Kraitzer A, et al. J Biomed Mater Res B Appl Biomater. 2008 May;85(2):583-603. doi: 10.1002/jbm.b.30974. J Biomed Mater Res B Appl Biomater. 2008. PMID: 18098192 Review.
Bioresorbable Stents in PCI.
Lindholm D, James S. Lindholm D, et al. Curr Cardiol Rep. 2016 Aug;18(8):74. doi: 10.1007/s11886-016-0750-9. Curr Cardiol Rep. 2016. PMID: 27312934 Review.
Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.
Moscarella E, Ielasi A, Granata F, Coscarelli S, Stabile E, Latib A, Cortese B, Tespili M, Tanaka A, Capozzolo C, Caliendo L, Colombo A, Varricchio A. Moscarella E, et al. Circ Cardiovasc Interv. 2016 Apr;9(4):e003148. doi: 10.1161/CIRCINTERVENTIONS.115.003148. Circ Cardiovasc Interv. 2016. PMID: 27059683
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.
Chang CC, Onuma Y, Achenbach S, Barbato E, Chevalier B, Cook S, Dudek D, Escaned J, Gori T, Kočka V, Tarantini G, West NEJ, Morice MC, Tijssen JGP, van Geuns RJ, Smits PC; COMPARE ABSORB trial investigators. Chang CC, et al. Cardiovasc Revasc Med. 2019 Jul;20(7):577-582. doi: 10.1016/j.carrev.2019.04.013. Epub 2019 Apr 16. Cardiovasc Revasc Med. 2019. PMID: 31153846 Free article.
Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Bourantas CV, Serruys PW. Gogas BD, et al. JACC Cardiovasc Interv. 2013 Mar;6(3):211-21. doi: 10.1016/j.jcin.2013.01.132. JACC Cardiovasc Interv. 2013. PMID: 23517830 Free article. Review.
A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, Costa JR Jr, Chamie D, Abizaid AS, Pinto I, Morrison L, Toyloy S, Bhat V, Yan J, Abizaid A. Verheye S, et al. JACC Cardiovasc Interv. 2014 Jan;7(1):89-99. doi: 10.1016/j.jcin.2013.07.007. Epub 2013 Oct 16. JACC Cardiovasc Interv. 2014. PMID: 24139932 Free article. Clinical Trial.
94 results